Accessibility Menu
Zentek logo

Zentek(NASDAQ) ZTEK

Current Price$0.54
Market Cap$67.31MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)+65%
5 Year-78%
1 Year-42%
1 Month+28%
Zentek last closing stock price
MetricPriceDate
Last closeUSD 0.532026-07-24
Zentek stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+13.08%USD 0.472026-07-17
1 month+28.1%USD 0.422026-06-24
3 month+13.06%USD 0.472026-04-24
Year to date-16.94%USD 0.642025-12-31
1 year-42.35%USD 0.922025-07-24
3 year-66.77%USD 1.602023-07-25
5 year-78.39%USD 2.462021-07-23
Since inception+64.58%USD 0.322012-03-30

Zentek Financials at a Glance

Market Cap

$67.31MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$166.09K

Net Income (TTM)

-CA$9.78M

EPS (TTM)

-$0.07

P/E Ratio

-7.98

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$0.54

Volume

6,226

Open

$0.53

Previous Close

$0.54

Daily Range

$0.52 - $0.56

52-Week Range

$0.37 - $1.24

Estimated Earnings Date

Jul 1, 2026

ZTEK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zentek

Zentek Ltd. is a Canadian company focused on the research and development of graphene and related nanomaterials. The company specializes in innovative products such as antimicrobial coatings, surgical masks, and rapid diagnostic tests, positioning itself as a leader in advanced materials technology.

Products and Services
  • Graphene-based antimicrobial coatings under the ZenGUARD brand
  • Surgical masks and personal protective equipment
  • Rapid detection diagnostics and pharmaceutical products
Growth Outlook
  • Expansion into healthcare markets with innovative graphene applications
  • Development of the Albany graphite project to enhance production capabilities
  • Increasing demand for advanced materials in various industries
Financial Highlights
  • Recent quarterly revenue of CAD 36,861, showing potential for growth
  • Trailing twelve months (TTM) revenue of CAD 1,000,000, indicating market interest
  • Cash and cash equivalents of CAD 1,306,104, providing operational liquidity
Zentek Ltd. operates in the promising field of graphene technology, which is gaining traction across multiple sectors, including healthcare and environmental applications. The company's innovative product line, particularly in antimicrobial solutions, positions it well to capitalize on the growing demand for advanced materials. The Albany graphite project further enhances its potential for growth, providing a strategic advantage in production capabilities. Recent financial data indicates a solid foundation, with a notable cash position that supports ongoing research and development efforts. As the market for graphene and related technologies expands, Zentek Ltd. is poised to play a significant role in shaping the future of advanced materials.
AI Generated • Jul 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10

CEO

Mohammed Jiwan

Website

www.zentek.com

Headquarters

Guelph, ON N1E 6Z1, CA

ZTEK Financials

Key Financial Metrics (TTM)

Gross Margin

-2519.08%

Operating Margin

-6322.76%

Net Income Margin

-5882.61%

Return on Equity

-81.71%

Return on Capital

-92.44%

Return on Assets

-64.74%

Earnings Yield

-12.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$67.31MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

126.62M

Volume

6.23K

Avg. Volume

204.32K

Financials (TTM)

Gross Profit

-CA$4.19M

Operating Income

-CA$10.51M

EBITDA

-CA$9.72M

Operating Cash Flow

-CA$5.07M

Capital Expenditure

-CA$378.49K

Free Cash Flow

-CA$5.45M

Cash & ST Invst.

CA$1.31M

Total Debt

CA$1.92M

Zentek Performance Analysis

Zentek annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 55,073-79.7%
20242024-03-31CAD 22,105-59.9%
20252025-03-31CAD 627,2712737.7%
20262026-03-31CAD 120,142-80.8%
Zentek sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-92.9%
Q22025-09-30-89.3%
Q32025-12-31951.3%
Q42026-03-31-43.5%
Zentek annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -0.11-60.1%
20242024-03-31CAD -0.09-21.3%
20252025-03-31CAD -0.07-18.8%
20262026-03-31CAD -0.07-4.9%
Zentek sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-3027.4%
Q22025-09-30-53.8%
Q32025-12-31-16.5%
Q42026-03-31-40.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$36.86K

-95.5%

Gross Profit

-CA$2.94M

-638.2%

Gross Margin

-79.74%

N/A

Market Cap

$67.31MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$6.73M

N/A

Employees

10

N/A

Net Income

-CA$3.54M

-92.2%

EBITDA

-CA$3.73M

-98.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CA$1.31M

+975.2%

Total Debt

CA$1.92M

+181.9%

Accounts Receivable

CA$372.21K

-69.1%

Inventory

CA$418.62K

-52.8%

Long Term Debt

CA$1.76M

+985.6%

Short Term Debt

CA$162.15K

-68.7%

Return on Assets

-64.74%

N/A

Return on Invested Capital

-90.87%

N/A

Free Cash Flow

-CA$736.82K

+46.3%

Operating Cash Flow

-CA$736.82K

+42.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HYFTMindWalk Holdings Corp.
$1.36+15.25%
MBOTMicrobot Medical Inc.
$1.71-2.84%
GUTSFractyl Health, Inc.
$0.77+2.15%
HYPRHyperfine, Inc.
$0.95+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%
TAT&T
$24.13+0.05%

Questions About ZTEK

What is the current price of Zentek?

Zentek is trading at $0.54 per share.

What is the 52-week range for Zentek?

Over the past 52 weeks, Zentek has traded between $0.37 and $1.24.

How much debt does Zentek have?

As of the most recent reporting period, Zentek reported total debt of CA$1.37M.

How much cash does Zentek have on hand?

Zentek reported CA$933.49K in cash and cash equivalents in its most recent financial results.

What is Zentek’s dividend yield?

Zentek does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services